Sifalimumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sifalimumab" in English language version.

refsWebsite

Global rank English rank

2^nd place

2^nd place

4^th place

4^th place

3,257^th place

3,398^th place

1web.archive.org

1^st place

1^st place

low place

low place

274^th place

309^th place

low place

low place

ama-assn.org

"Statement On A Nonproprietary Name Adopted By The USAN Council: Sifalimumab" (PDF). American Medical Association.

doi.org

Greth W, Robbie GJ, Brohawn P, Hultquist M, Yao B (January 2017). "Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus". Immunotherapy. 9 (1): 57–70. doi:10.2217/imt-2016-0090. PMID 28000522.

medimmune.com

"Press release: New Hope for Lupus Patients". MedImmune. 11 August 2015. Archived from the original on 31 July 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Greth W, Robbie GJ, Brohawn P, Hultquist M, Yao B (January 2017). "Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus". Immunotherapy. 9 (1): 57–70. doi:10.2217/imt-2016-0090. PMID 28000522.

springer.com

adisinsight.springer.com

"Sifalimumab". AdisInsight. Springer Nature Switzerland AG. Retrieved 31 July 2017.

sps.nhs.uk

"Sifalimumab". NHS Specialist Pharmacy Service. Retrieved 31 July 2017.

web.archive.org

"Press release: New Hope for Lupus Patients". MedImmune. 11 August 2015. Archived from the original on 31 July 2017.